Article
Effects of two hypertrophic cardiomyopathy mutations in alpha-tropomyosin, Asp175Asn and Glu180Gly, on Ca2+ regulation of thin filament motility.
Biochemical and biophysical research communications - 30 Jul 1997
Bing W, Redwood C S, Purcell I F, Esposito G, Watkins H, Marston S B
Abstract excerpt
The functional properties of wild type alpha-tropomyosin expressed in E. coli with an alanine-serine N-terminal leader (AS-alpha-Tm) were compared with those of AS-alpha-Tm with either of two missense mutations (Asp175Asn and Glu180Gly) shown to cause familial hypertrophic cardiomyopathy (FHC). Wild type AS-alpha-Tm and AS-alpha-Tm(Asp175Asn) binding to actin was indistinguishable from rabbit skeletal muscle...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
